October 24, 2001 Microcide Pharmaceuticals, Inc. 850 Maude Avenue Mountain View, CA 94043 Attention: Chief Financial Officer Ladies and Gentlemen: Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and _____________________ (the...Prospect Venture Partners Ii Lp • November 5th, 2001 • Pharmaceutical preparations
Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and _____________________ (the "Investor"), have entered into a Subscription Agreement dated as of July 27, 2001 (the "Subscription Agreement"), providing for the purchase of __________________ shares (the "Shares") of the Company's Series B Convertible Redeemable Preferred Stock ("Company Preferred Stock") by the Investor (the "Investment").
Exhibit 99.3 FORM OF VOTING AGREEMENT MICROCIDE PHARMACEUTICALS, INC. VOTING AGREEMENT THIS VOTING AGREEMENT (the "Agreement") is made and entered into as of this 24th day of October, 2001, by and between MICROCIDE PHARMACEUTICALS, INC., a Delaware...Voting Agreement • November 5th, 2001 • Prospect Venture Partners Ii Lp • Pharmaceutical preparations • Delaware
Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of this Statement on Schedule 13D including any amendments thereto. This...Joint Filing Agreement • November 5th, 2001 • Prospect Venture Partners Ii Lp • Pharmaceutical preparations
Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of this Statement on Schedule 13D including any amendments thereto. This Joint Filing Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.
